All 260 IBBQ (INVESCO NASDAQ BIOTECHNOLOGY ETF) Holdings
There are 260 IBBQ holdings. Top 10 companies weight: 40.98%.
Total Market Cap: $1.60T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (260 stocks) | +19.22% | 19.98 | 14.69 | 0.43 | +38.01% | +8.17% | 0.75 | ||||||||||
101 | PHVS | Pharvaris Nv Ordinary Shares | 0.15% | $30.14 | $1.92B | Biotechnology | Healthcare | +9.20% | N/A | N/A | N/A | N/A | N/A | 78 | +54.08% | $46 | +8.09% | 0.71 |
102 | TRVI | Trevi Therapeutics Inc | 0.15% | $13.45 | $1.86B | Biotechnology | Healthcare | -27.09% | N/A | N/A | N/A | N/A | N/A | 79 | +77.70% | $24 | +44.88% | 0.64 |
103 | ANIP | Ani Pharmaceuticals Inc | 0.15% | $75.23 | $1.71B | Drug Manufacturers - Specialty & Generic | Healthcare | +25.74% | 20.61 | 9.29 | 0.01 | N/A | N/A | 81 | +46.06% | $110 | +16.95% | 0.64 |
104 | TYRA | Tyra Biosciences Inc | 0.14% | $28.69 | $1.97B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +78.29% | $51 | 0.00% | 1.04 |
105 | INVA | Innoviva Inc | 0.14% | $21.70 | $1.63B | Biotechnology | Healthcare | +16.74% | 3.19 | 11.12 | 0.33 | N/A | N/A | 62 | +63.59% | $36 | +10.82% | 0.22 |
106 | HRMY | N/A | 0.14% | $32.10 | $1.78B | Biotechnology | Healthcare | N/A | 12.18 | 10.08 | N/A | N/A | N/A | 63 | +38.19% | $44 | -0.67% | 0.69 |
107 | SRPT | Sarepta Therapeutics Inc | 0.14% | $16.24 | $1.76B | Biotechnology | Healthcare | N/A | 4.62 | 5.29 | 159.25 | N/A | N/A | 51 | +35.47% | $22 | -25.96% | 1.39 |
108 | SNDX | Syndax Pharmaceuticals Inc | 0.14% | $18.34 | $1.74B | Biotechnology | Healthcare | +12.13% | N/A | N/A | N/A | N/A | N/A | 78 | +114.01% | $39 | +0.54% | 1.07 |
109 | NVAX | Novavax Inc | 0.14% | $10.20 | $1.82B | Biotechnology | Healthcare | -42.97% | N/A | 2.59 | 1.32 | N/A | N/A | 50 | +38.33% | $14 | -43.87% | 1.47 |
110 | NRIX | Nurix Therapeutics Inc Ordinary Shares | 0.14% | $15.48 | $1.81B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +94.96% | $30 | -12.02% | 1.35 |
111 | STOK | Stoke Therapeutics Inc | 0.14% | $29.46 | $1.96B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +53.09% | $45 | -4.61% | 1.09 |
112 | IOVA | Iovance Biotherapeutics Inc | 0.14% | $3.79 | $1.91B | Biotechnology | Healthcare | -12.60% | N/A | N/A | N/A | N/A | N/A | 75 | +132.19% | $8.80 | -26.71% | 1.67 |
113 | GMAB | Genmab As Adr | 0.14% | $23.88 | $17B | Biotechnology | Healthcare | -12.66% | 40.20 | 14.95 | 1.75 | N/A | N/A | 70 | +54.19% | $37 | -10.22% | 0.62 |
114 | VCEL | Vericel Corp | 0.14% | $34.74 | $1.75B | Biotechnology | Healthcare | +35.66% | 80.63 | 68.97 | 0.14 | N/A | N/A | 71 | +59.56% | $55 | -9.01% | 1.19 |
115 | ANAB | Anaptysbio Inc | 0.13% | $51.24 | $1.67B | Biotechnology | Healthcare | -4.15% | N/A | N/A | N/A | N/A | N/A | 79 | +64.81% | $84 | +27.51% | 0.81 |
116 | AGIO | Agios Pharmaceuticals Inc | 0.13% | $27.68 | $1.70B | Biotechnology | Healthcare | N/A | N/A | 2.47 | N/A | N/A | N/A | 67 | +47.69% | $41 | -13.63% | 1.08 |
117 | QURE | Uniqure Nv | 0.13% | $29.88 | $1.59B | Biotechnology | Healthcare | +2.11% | N/A | 27.93 | N/A | N/A | N/A | 69 | +30.96% | $39 | -3.29% | 1.32 |
118 | ABCL | Abcellera Biologics Inc Ordinary Shares | 0.13% | $5.72 | $1.65B | Biotechnology | Healthcare | N/A | N/A | 27.55 | N/A | N/A | N/A | 75 | +82.34% | $10 | -26.11% | 1.62 |
119 | VIR | Vir Biotechnology Inc | 0.12% | $8.77 | $1.47B | Biotechnology | Healthcare | -0.01% | N/A | 4.27 | N/A | N/A | N/A | 82 | +134.44% | $21 | -27.88% | 1.54 |
120 | GHRS | Gh Research Plc | 0.12% | $24.43 | $1.39B | Biotechnology | Healthcare | +89.13% | N/A | N/A | N/A | N/A | N/A | 83 | +61.69% | $40 | 0.00% | 1.01 |
121 | GLUE | Monte Rosa Therapeutics Inc | 0.12% | $17.59 | $1.62B | Biotechnology | Healthcare | N/A | N/A | 10.02 | N/A | N/A | N/A | 81 | +83.80% | $32 | 0.00% | 1.35 |
122 | MBX | Mbx Biosciences Inc | 0.12% | $30.05 | $1.52B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +129.92% | $69 | 0.00% | 1.47 |
123 | NTLA | Intellia Therapeutics Inc | 0.12% | $13.02 | $1.62B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +104.53% | $27 | -29.01% | 1.71 |
124 | INBX | Inhibrx Biosciences Inc | 0.12% | $95.22 | $1.50B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 66 | +191.43% | $278 | 0.00% | 1.39 |
125 | ARDX | Ardelyx Inc | 0.12% | $5.42 | $1.52B | Biotechnology | Healthcare | -26.76% | N/A | 40.65 | N/A | N/A | N/A | 77 | +201.29% | $16 | -4.29% | 0.81 |
126 | TSHA | N/A | 0.12% | $5.55 | $1.65B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +120.36% | $12 | -24.30% | 1.39 |
127 | AMLX | Amylyx Pharmaceuticals Inc | 0.12% | $13.20 | $1.56B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 2.77 | N/A | N/A | N/A | 72 | +77.27% | $23 | 0.00% | 1.15 |
128 | PGEN | Precigen Inc | 0.12% | $3.81 | $1.55B | Biotechnology | Healthcare | -3.77% | N/A | 204.08 | N/A | N/A | N/A | 75 | +226.77% | $12 | -10.60% | 1.66 |
129 | ATAI | Ataibeckley Inc | 0.12% | $4.53 | $1.58B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +209.05% | $14 | 0.00% | 1.45 |
130 | RXRX | Recursion Pharmaceuticals Inc Class A | 0.12% | $3.47 | $1.68B | Biotechnology | Healthcare | -10.03% | N/A | N/A | N/A | N/A | N/A | 65 | +91.35% | $6.64 | -34.79% | 2.60 |
131 | KALV | Kalvista Pharmaceuticals Inc | 0.11% | $26.95 | $1.37B | Biotechnology | Healthcare | +11.29% | N/A | 25.45 | N/A | N/A | N/A | 60 | +6.12% | $29 | +0.39% | 0.87 |
132 | n/a | Urogen Pharma Ltd | 0.11% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
133 | SEPN | Septerna Inc | 0.11% | $30.55 | $1.34B | Biotechnology | Healthcare | N/A | N/A | 107.53 | N/A | N/A | N/A | 77 | +44.84% | $44 | 0.00% | 1.32 |
134 | BCAX | Bicara Therapeutics Inc | 0.11% | $20 | $1.41B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +57.30% | $31 | 0.00% | 1.43 |
135 | IMCR | Immunocore Holdings Plc Adr | 0.10% | $28.65 | $1.45B | Biotechnology | Healthcare | N/A | N/A | 196.08 | N/A | N/A | N/A | 70 | +121.61% | $63 | -6.01% | 0.73 |
136 | FTRE | Fortrea Holdings Inc | 0.10% | $15.63 | $1.27B | Biotechnology | Healthcare | N/A | N/A | 9.38 | 0.34 | N/A | N/A | 56 | +3.71% | $16 | 0.00% | 1.88 |
137 | HROW | Harrow Inc | 0.10% | $33.32 | $1.28B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 227.27 | N/A | N/A | N/A | 75 | +103.33% | $68 | +29.87% | 1.78 |
138 | MAZE | Maze Therapeutics Inc | 0.10% | $24.86 | $1.30B | Biotechnology | Healthcare | N/A | N/A | 8.53 | N/A | N/A | N/A | 77 | +151.61% | $63 | 0.00% | 0.88 |
139 | WVE | Wave Life Sciences Ltd | 0.10% | $5.76 | $1.22B | Biotechnology | Healthcare | -19.81% | N/A | N/A | N/A | N/A | N/A | 78 | +280.90% | $22 | -3.18% | 1.46 |
140 | ALVO | Alvotech | 0.09% | $3.14 | $1.14B | Drug Manufacturers - Specialty & Generic | Healthcare | -18.97% | N/A | 7.91 | N/A | N/A | N/A | 62 | +340.45% | $14 | 0.00% | 0.79 |
141 | EYPT | Eyepoint Inc | 0.09% | $12.34 | $1.10B | Biotechnology | Healthcare | +6.42% | N/A | 6.16 | N/A | N/A | N/A | 80 | +199.84% | $37 | +6.14% | 1.30 |
142 | OLMA | N/A | 0.09% | $10.51 | $1.13B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +297.91% | $42 | -17.63% | 0.71 |
143 | CRVS | Corvus Pharmaceuticals Inc | 0.09% | $11.60 | $1.09B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +33.95% | N/A |
144 | MNKD | Mannkind Corp | 0.09% | $3.36 | $1.10B | Biotechnology | Healthcare | -21.18% | N/A | 37.31 | 4.39 | N/A | N/A | 71 | +125.89% | $7.59 | -1.43% | 0.71 |
145 | AVBP | Arrivent Biopharma Inc | 0.09% | $29.78 | $1.24B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +41.37% | $42 | 0.00% | 0.94 |
146 | CMPS | Compass Pathways Plc Adr | 0.09% | $12.69 | $1.60B | Medical Care Facilities | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +74.94% | $22 | -17.50% | 1.41 |
147 | COLL | Collegium Pharmaceutical Inc | 0.09% | $31.06 | $1.09B | Drug Manufacturers - Specialty & Generic | Healthcare | -5.45% | 36.96 | 4.28 | N/A | N/A | N/A | N/A | N/A | N/A | +7.33% | N/A |
148 | SVRA | Savara Inc | 0.08% | $5.25 | $1.07B | Biotechnology | Healthcare | -2.12% | N/A | 0.41 | N/A | N/A | N/A | 81 | +105.90% | $11 | +23.74% | 1.20 |
149 | ZBIO | Zenas Biopharma Inc | 0.08% | $17.40 | $1.13B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +142.07% | $42 | 0.00% | 1.30 |
150 | GRFS | Grifols Sa Adr | 0.08% | $7.47 | $5.48B | Drug Manufacturers - General | Healthcare | -10.20% | 11.29 | 8.73 | 0.08 | N/A | N/A | 62 | +45.52% | $11 | -14.76% | 0.89 |
IBBQ (INVESCO NASDAQ BIOTECHNOLOGY ETF) Sector Allocation
HEALTHCARE
93.90%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%